Biogen (BIIB) Leases (2016 - 2025)
Historic Leases for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $265.4 million.
- Biogen's Leases fell 2553.31% to $265.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $265.4 million, marking a year-over-year decrease of 2553.31%. This contributed to the annual value of $265.4 million for FY2025, which is 2553.31% down from last year.
- According to the latest figures from Q4 2025, Biogen's Leases is $265.4 million, which was down 2553.31% from $330.5 million recorded in Q3 2025.
- In the past 5 years, Biogen's Leases ranged from a high of $460.9 million in Q3 2023 and a low of $265.4 million during Q4 2025
- Over the past 5 years, Biogen's median Leases value was $384.8 million (recorded in 2021), while the average stood at $378.4 million.
- As far as peak fluctuations go, Biogen's Leases soared by 1413.89% in 2023, and later tumbled by 2553.31% in 2025.
- Quarter analysis of 5 years shows Biogen's Leases stood at $375.4 million in 2021, then rose by 7.59% to $403.9 million in 2022, then rose by 3.99% to $420.0 million in 2023, then fell by 15.14% to $356.4 million in 2024, then dropped by 25.53% to $265.4 million in 2025.
- Its Leases was $265.4 million in Q4 2025, compared to $330.5 million in Q3 2025 and $334.5 million in Q2 2025.